CONTENT AND LEARNING OBJECTIVES

The menopause transition is associated with significant hormonal and physiological changes, and growing research is exploring the potential role of the gut and vaginal microbiomes in this process. Of particular interest is the estrobolome, the collection of gut microbial genes involved in oestrogen metabolism, and how changes in microbial composition and function may interact with declining and fluctuating oestrogen levels across perimenopause and menopause.

In this webinar, we will explore the emerging relationship between the estrobolome, gut health and the menopause transition. We will examine how gut microbes may influence oestrogen metabolism, how the gut and vaginal microbiomes can change across perimenopause and menopause, and what these changes may mean for gastrointestinal symptoms, genitourinary syndrome of menopause (GSM) and metabolic health.

The session will also take a critical look at this rapidly evolving area of research, considering what the evidence currently tells us, where important gaps remain and how findings can be interpreted in practice. We will explore the developing evidence for diet, lifestyle and microbiome-targeted approaches, including probiotics, and consider how practitioners can translate the science into appropriate, evidence-informed nutrition guidance.

This webinar is kindly supported by Optibac

About Optibac​

Optibac are experts and leaders in the market of probiotics in UK and Ireland. With 2 decades of expertise specialising entirely in probiotics formulations, they understand the importance of strain specificity, a fact recognised by WHO and IPA. This acknowledgement drives Optibac to partner with leading microbial institutes worldwide and work with some of the most extensively researched strains available, reflecting the company’s commitment to quality. Every Optibac strain undergoes rigorous testing to ensure they reach the gut alive. Education is another cornerstone of their values.